baber/WOPTO huggingface dataset:
Patent AU-680976-B2 (AU)
Title: Rail of high abrasion resistance and high tenacity having pearlite metallographic structure and method of manufacturing the same
Inventor: UCHINO KOUICHI
IPC: C21D8/00
Filed: 1994-12-19
Granted: 1997-08-14
Abstract: This invention relates to a high-tenacity rail having a strength, an abrasion resistance, and a high carbon pearlite structure excellent in ductility and tenacity; and a method of manufacturing the same. A high-tenacity rail having elongation of not less than 12 % and a U-notch Charpy impact value of not less than 25 J/cm<2> obtained by forming fine pearlite blocks by a special rolling operation in steel of a high abrasion resistance containing 0.60-1.20 wt.% of C, 0.10-1.20 wt.% of Si and 0.40-1.50 wt.% of Mn, and one or not less than two kinds of elements out of Cr, Mo, V, Nb and Co as necessary; and a method of manufacturing the same. This invention enables the ductility and tenacity of a high carbon steel rail of a high abrasion resistance to be improved, and a rail of a high safety to be provided for railways in a cold district. <IMAGE>
Patent AU-738151-B2 (AU)
Title: Process and device for the detection of the rectifier effect appearing in a gas discharge lamp
Inventor: PRIMISSER NORBERT
IPC: H05B41/28
Filed: 1998-11-19
Granted: 2001-09-13
Abstract: Process for the recognition of the rectifier effect appearing in a gas discharge lamp (G1, G2) and an electronic ballast, for the operation of gas discharge lamps (G1, G2), with which such a process finds employment. The electronic ballast includes a monitoring or control circuit (IC2) which monitors an operating parameter of a load circuit (E) of the electronic ballast, whereby this operating parameter corresponds to the lamp voltage or is dependent thereon. The monitoring circuit (IC2) integrates this monitored operating parameter over a full period and determines upon the presence of a rectifier effect if the integration result deviates from a predetermined integration desired value. Further, for the recognition of the rectifier effect, the duration of the positive and negative half-waves of the monitored parameter can be compared.
Patent AU-736884-B2 (AU)
Title: Computerized orthodontic diagnosis and appliance dispenser
Inventor: BERGERSEN EARL O
IPC: A61C7/00
Filed: 1998-10-28
Granted: 2001-08-02
Abstract: A method and apparatus for diagnosing orthodontic conditions of an individual. The apparatus includes an outer case and a user interface disposed on the outer case for communicating with the individual. The apparatus further has diagnostic hardware including at least one digital camera carried within the case adapted to take a plurality of video images of the teeth and mouth of the individual. The apparatus further has electronic circuitry which is preprogrammed with statistical data for comparison to actual data collected by the diagnostic hardware and transmitted to the electronic circuitry. The circuitry is further adapted to diagnose whether the individual has correctable orthodontic conditions. The apparatus is further adapted to dispense instructions to the individual for receiving proper corrective orthodontic care. The method of the invention includes providing an apparatus adapted to take various digital images of the individual's teeth and mouth. The digital images are analyzed by the electronic circuitry and compared to the statistical data preprogrammed within the apparatus for diagnosing whether the individual has correctable orthodontic conditions. The method further includes the steps of informing the individual as to whether their orthodontic conditions are correctable and instructing the individual on how to correct the orthodontic conditions diagnosed and dispensing an appropriate appliance.
Patent AU-711366-B2 (AU)
Title: Complementary adenoviral vector systems and cell lines
Inventor: KOVESDI IMRE
IPC: A61K39/00
Filed: 1996-12-12
Granted: 1999-10-14
Abstract: The present invention provides multiply replication deficient adenoviral vectors having a spacer in at least one replication deficient adenoviral region, as well as complementing cell lines therefor. Also provided are means of constructing the multiply replication deficient adenoviral vectors and methods of use thereof, e.g., in gene therapy.
Patent AU-620028-B2 (AU)
Title: Bicycle saddle
Inventor: BEYLET DANIEL
IPC: B62J1/18
Filed: 1988-04-08
Granted: 1992-02-13
Abstract: Saddle, characterised in that it comprises, at one of its ends, an anatomical raised edge (4) having, on its front side, a symmetrical relief formed from two concavities on either side of a central, longitudinal projecting zone (6), the said central longitudinal zone terminating, at the upper part, in an upper central wedge (9) which makes it possible to obtain an efficient support/wedging. 
<??>This invention is of interest to professional cyclists and manufacturers of accessories. 
<IMAGE>
Patent AU-699922-B2 (AU)
Title: Deodorant composition containing a compound which yields formaldehyde
Inventor: ELSHOUT WILHELMUS HENDRICUS HU
IPC: A61L9/04
Filed: 1995-01-30
Granted: 1998-12-17
Abstract: PCT No. PCT/NL95/00043 Sec. 371 Date Aug. 15, 1996 Sec. 102(e) Date Aug. 15, 1996 PCT Filed Jan. 30, 1995 PCT Pub. No. WO95/22309 PCT Pub. Date Aug. 24, 1995The invention relates to a product for preventing and controlling bad smells caused by human perspiration containing at least one compound (a) which yields an aldehyde, in particular formaldehyde, under the influence of human perspiration fluid, wherein compound (a) is preferably selected from hexamethylene tetramine (HMTA), para-formaldehyde and trioxane, the use of compound (a) as well as a container containing product (a) in the form of a liquid preparation.
Patent AU-570205-B2 (AU)
Title: Nystatin pastille formulation
Inventor: RIDGWAY FRANK
IPC: C07H17/08
Filed: 1983-06-02
Granted: 1988-03-10
Abstract: A nystatin gelatin-based pastille formulation is provided which is soft in texture and when dissolved slowly in the mouth does not cause irritation of oral mucosa and yet provides nystatin in sufficiently high saliva concentrations for periods of time so as to be particularly effective in the treatment of candidiasis in the oral cavity and esophagus.
Patent AU-594243-B2 (AU)
Title: A computer-controlled switching system, in particular a so-called key telephone switching system
Inventor: ROTH ROLAN
IPC: H04M3/54
Filed: 1988-06-15
Granted: 1990-03-01
Abstract: To transfer a call, the ringing signal is first of all supplied successively by the central control device (ZSt) to the individual terminals within a group of specially selected subscriber terminals according to the sequence defined in a list (L) in the customer data store (KD) until the call is set up. Following unsuccessful call attempts within this group, the ringing signal is supplied in a defined sequence to all the other terminals, with the exception of one or more which are correspondingly stored. This may be carried out in ascending order, starting with the lowest telephone number. This type of call transfer is normally implemented for external incoming call requests only. Each exchange line (L3) may be allocated its own individual group of terminals. <IMAGE>
Patent AU-604347-B2 (AU)
Title: Nutrient mixture intended for the elderly
Inventor: DARMENTON PATRICK
IPC: A23L33/155
Filed: 1988-07-22
Granted: 1990-12-13
Abstract: Polymeric, complete food mixture in the form of a fine emulsion, intended for oral or enteral feeding of the elderly, which mixture contains . calcium (> 0.066 g/100 ml) in combination with fluorine (0.05 to 0.25 mg/100 ml) and vitamin D (60 to 110 IU/100 ml),  . folic acid (0.13 to 0.4 mg/100 ml), and . zinc (2 to 4.0 mg/100 ml).
Patent AU-668351-B2 (AU)
Title: Monoclonal antibodies against human TNF-binding protein I (TNF-BP I)
Inventor: ADOLF GUNTHER
IPC: A61K38/00
Filed: 1992-06-13
Granted: 1996-05-02
Abstract: The invention concerns monoclonal antibodies, designated tbp-1, tbp-2 and tbp-6, against the extracellular part of the human 60 kD TN tumour necrosis factor receptor (TNF-BP I). These antibodies are suitable for use in highly sensitive immuno-assays for demonstrating the presence of TNF-BP I in body fluids, including urine, and in cell-culture residues. The determination of the TNF-BP I concentration as the basis for a diagnosis of pathological conditions associated with activation of the TNF receptor system is thus particularly useful if the  alpha -TNF concentration in the organism falls more rapidly than the TNF-BP I concentration. In addition, tbp-1 and tbp-6 can be used to strengthen the protective action of TNF-BP I against  alpha -TNF and/or  beta -TNF.
Patent AU-659846-B2 (AU)
Title: A process for producing suppositories by compression and suppositories obtained by the process
Inventor: HALSKOV SOREN
IPC: A61K47/34
Filed: 1992-06-16
Granted: 1995-06-01
Abstract: Suppositories which may have a considerably higher content of an active drug than ordinary suppositories, are produced by compressing a suppository mass, which contains a considerable amount of a polyethylene glycol having a molecular weight of at least 4000, preferably 6000. The polyethylene glycol constitutes 20-50 % by weight of the suppository mass, which moreover contains microcrystalline cellulose and/or other additives common in the production of drugs. The obtained suppositories are more convenient to store and use, easier to produce and considerably more concentrated with respect to active substance (up to 75 % by weight) than traditional melt-moulded suppositories.
Patent AU-664038-B2 (AU)
Title: Locking arrangement consisting of key and lock cylinder
Inventor: SIEG GISELHER
IPC: E05B27/08
Filed: 1992-07-23
Granted: 1995-11-02
Abstract: The locking arrangement consists of key a (2) and lock cylinder (1) with a guide cross section (21) provided on the rear of the key shank (18) and with profiled longitudinal ribs arranged on the broad face for entry into associated grooves of the lock cylinder key channel (16). Transversely to the profiled longitudinal ribs, there are provided wards (41) which issue from one narrow edge (40) of the key shank and, in their depth, follow the unit or multiple of the step jump (x) of the lock cylinder core pins (15). At least the lower rib flank (U, U') facing the narrow edge (40) of the key shank is perpendicular to the longitudinal centre plane of the key shank and the distance of the lower rib flanks (U, U') from one another is equal. The lower rib flanks (U, U') are arranged at a distance from one another corresponding to the unit or integral multiple of the step jump (x) and in such a way that the deepest points of the wards (41) are at the level of the lower rib flanks (U, U') which externally pass tangentially into convexly shaped curved end faces (42, 42') which run tangentially into the upper rib flanks (O, O'). <IMAGE>
Patent AU-611477-B2 (AU)
Title: A filter for use in a cartridge for the preparation of a beverage
Inventor: FAVRE ERIC
IPC: A47J31/06
Filed: 1988-09-14
Granted: 1991-06-13
Abstract: This filter comprises uniformly distributed openings (2) of the same size, each having a frustoconical shape, the diameter of the minor base (4) being between 0.1 and 0.3 mm and that of the major base (5) being between 0.2 and 0.5 mm. 
<IMAGE>
Patent AU-757869-B2 (AU)
Title: Apparatus for gas treatment of products
Inventor: MALMBERG JONNY
IPC: A23L3/40
Filed: 2000-01-20
Granted: 2003-03-06
Abstract: A high-pressure chamber in an apparatus for gas treatment of products is located adjacent a tunnel (11) in said apparatus, said tunnel (11) having perforated walls (12) and enclosing a conveyor belt (8) for transporting the products. The high-pressure chamber (14) comprises walls (15-17) being connected with perforated walls (12) of the tunnel (11) in order to form said high-pressure chamber (14), said walls (15-17) forming the high-pressure chamber (14) comprising an opening towards and connected to an outlet of a gas circulation means (18) so that the high-pressure chamber (14) constitutes a gas circulation channel from said outlet of the gas circulation means (18) to the perforated walls (12) of the tunnel (11). The chamber (14) is located substantially above the tunnel (11). The walls (15-17) forming the high-pressure chamber (14) comprise substantially vertical side walls (15-16), and at least one substantially vertical part of said side walls (15-16) is removable so as to provide access to the inside of the high-pressure chamber (14). <IMAGE>
Patent AU-580729-B2 (AU)
Title: Chromene derivatives
Inventor: TIMAR TIBOR
IPC: A01N43/16
Filed: 1984-02-15
Granted: 1989-02-02
Abstract: The invention relates to pesticidal compositions comprising as active ingredient a compound of the general Formula I    <IMAGE>  (I) wherein R1 and R2 stand for hydrogen, optionally halogenosubstituted C1-6 alkyl or aryl; R3 and R4 are hydrogen, halogen or C1-6 alkyl; R5, R6, R7 and R8 are hydrogen, hydroxy, mercapto, amino, C1-10 alkyl; a group containing a methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec. butoxy, isobutoxy, tert. butoxy, n-pentyloxy, cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, cyclohexyloxy, cycloheptyloxy, cyclooctyloxy, allyloxy, crotyloxy, prenyloxy, propargyloxy, substituted propargyloxy, C1-3 alkylenedioxy, aralkoxy, substituted aralkoxy, hydroxyalkoxy, alkoxyalkoxy, mercaptoalkoxyalkoxy, halogenoalkoxy, dihalogenoalkoxy, trihalogenoalkoxy, polyhalogenoalkoxy, N,N-dialkylaminoalkoxy, cycloalkylaminoalkoxy, alkylenoxy-alkyleneoxy, alkylene-thia-alkylenoxy or alkylene-aza-alkylenoxy unit or C2-6 acyl or a salt thereof and to a process for the preparation of the active ingredient.
Patent AU-610953-B2 (AU)
Title: Titanocenes, the use thereof, and n-substituted pyrroles
Inventor: HUSLER RINALDO
IPC: G03F7/027
Filed: 1988-12-01
Granted: 1991-05-30
Abstract: Titanocenes containing two 5-membered cyclodienyl groups, for example cyclopentadienyl, and one or two 6-membered carbocyclic or 5- or 6-membered heterocyclic aromatic rings which are substituted by a fluorine atom in at least one of the two ortho-positions to the titanium-carbon bond and contain, as a further substituent, unsubstituted or substituted 1-pyrryl, are suitable as photoinitiators for radiation-induced polymerization of ethylenically unsaturated compounds.
Patent AU-606556-B2 (AU)
Title: High nickel chromium alloy
Inventor: SMITH GAYLORD DARRELL
IPC: C22C19/05
Filed: 1988-12-05
Granted: 1991-02-07
Abstract: A high-nickel-chromium iron alloy containing aluminum and titanium is particularly useful under high temperature/oxidizing conditions such as encountered in ceramic tile industry frit-firing applications. The alloy also contains a special percentage of nitrogen as well as zirconium. The alloy composition is about 19 to 28% chromium, about 55 to 75% nickel, about 0.75 to 2% aluminum, up to about 1% titanium, zirconium in a small but effective amount sufficient to facilitate the manufacturing process and up to about 0.5%, up to 1% each of silicon, molybdenum, manganese and niobium, up to about 0.1% carbon, a small but effective amount of nitrogen sufficient to combine with the zirconium to effect grain size control and up to about 0.1%, up to about 0.2% yttrium, with the balance being iron.
Patent AU-722600-B2 (AU)
Title: Composition for the direct dyeing of keratin fibres with a cationic direct dye and a polyol and/or a polyol ether
Inventor: RONDEAU CHRISTINE
IPC: A61K8/40
Filed: 1999-05-12
Granted: 2000-08-10
Abstract: Composition for direct dyeing of human hair comprising a selected direct cationic dye of formula (I), (II), (III) or (III') and a polyol or an aliphatic or aromatic ether of a polyol. Composition for direct dyeing of keratinic fibers and particularly human hair comprising, in a suitable medium free from oxydases or oxydoreductases: (i) at least one direct cationic dye of formula (I), (II), (III) or (III'); and (ii) at least one polyol and/or a 1-8 C aliphatic ether of a 3-9 C polyol and/or a 6-8 C aromatic ether of a 2-9 C polyol.
Patent AU-710106-B2 (AU)
Title: Calcium binding recombinant antibody against protein c
Inventor: REZAIE ALIREZA
IPC: A61P43/00
Filed: 1995-06-09
Granted: 1999-09-16
Abstract: A Ca<2+> dependent recombinant antibody that specifically binds to a specific twelve peptide sequence (E D Q V D P R L I D G K) in the activation region of the Protein C has been constructed. The antibody does not bind to Activated Protein C and can be used to inhibit activation of Protein C by thrombin-thrombomodulin, in purification of Protein C, and in treatment of tumors.
Patent AU-731146-B2 (AU)
Title: Inorganic ion receptor-active compounds
Inventor: MOE SCOTT T
IPC: A61P19/00
Filed: 1997-04-30
Granted: 2001-03-22
Abstract: The present invention features compounds able to modulate one or more activities of an inorganic ion receptor and methods for treating diseases or disorders using such compounds. Preferred compounds can mimic or block the effect of extracellular calcium on a cell surface calcium receptor.
Patent AU-763951-B2 (AU)
Title: The traffic information and pricing (TIP) system
Inventor: JONGE WIEBREN DE
IPC: G07B15/02
Filed: 2000-03-09
Granted: 2003-08-07
Abstract: The TIP-system concerns a class of systems for collecting and/or disseminating information in relation to traffic, whereby information about individual persons and/or vehicles can be collected and checked on reliability (trustworthiness) in such a way that yet sufficient (privacy) protection can be offered against illegitimate tracing of individual persons and/or vehicles. Also, these systems can easily be prepared for future expansion (extensions), refinements and possible other changes. So, one may start using a simple variation and gradually introduce more and more applications and refinements. TIP-systems can be used, for example, for imposing all sorts of traffic fees, that is, for traffic pricing. In case of road traffic it is, for example, possible to charge for all distances traveled and to relate the fee for each distance unit traveled, if desired, to the place where and/or to the date, the point in time and/or the traffic intensity when that distance unit was traveled, to the brand, model, year of make, gearbox type and engine type of the vehicle used to the gear engaged, the number of revolutions, the fuel consumption, the noise production, the speed and/or speed changes when traveling the distance unit with that vehicle, and/or to the environmental pollution caused. Reducing noise nuisance by aircraft is another example of a possible application. Keywords: electronic toll collection (ETC), traffic pricing, proportionate pricing, continuous pricing, discrete pricing, odometer-based fee, mileage fee, kilometer fee, kilometer tax, road pricing, congestion pricing, pollution pricing, privacy protection, tracing, fraud resistance, controls, checks, verification, identification, semi-identification, agent, hunter, intermediary, reachability, congestion, traffic congestion information, traffic delay, environmental pollution, fuel consumption, noise nuisance, traffic fee, traffic tax, toll, meter reading, odometer, speedometer, tachometer, revolution-counter, automatic calibration, cruise control, rolling tester, taximeter, tachograph, black box.
Patent AU-565776-B2 (AU)
Title: Bearing device for chairs
Inventor: BAUER HANS-PETER
IPC: A47C1/024
Filed: 1984-09-21
Granted: 1987-09-24
Abstract: A height-adjustable office chair having an incline-adjustable seat and back includes a bearing device to which is connected a length-adjustable seat pneumatic spring connected by an articulated joint to the seat structure, a length-adjustable back-rest pneumatic spring connected to the back by an articulated joint, and a height-adjustable pneumatic spring. The actuating rods of all three of these pneumatic springs are in the bearing device and are controlled by an actuating lever movable both horizontally and vertically. Vertical movement of the actuating lever controls the height-adjustable pneumatic spring. Horizontal movement of the actuating lever serves to control one of two intermediate levers which are respectively arrestable and lockable by a detent lever located above the height-adjustable pneumatic spring.
Patent AU-768069-B2 (AU)
Title: Riluzole and levodopa combinations for treating Parkinson's disease
Inventor: BLANCHARD-BREGEON VERONIQUE
IPC: A61K31/428
Filed: 1999-04-22
Granted: 2003-12-04
Abstract: The invention concerns a combination of levodopa and riluzole or a pharmaceutically acceptable salt of said compound and the use of said combination for treating Parkinson Disease.
Patent AU-666707-B2 (AU)
Title: Monoclonal anti-ganglioside antibody, its preparation and use as a tumortherapeutic agent
Inventor: BOSSLET KLAUS
IPC: A61K39/395
Filed: 1993-03-18
Granted: 1996-02-22
Abstract: The invention relates to monoclonal antibodies which have high avidity and react specifically with gangliosides GD3 and GQ1b, and to the use thereof for detecting melanomas and other GD3 and GQ1b expressing tumours or tissues.
Patent AU-756544-B2 (AU)
Title: 2,3-olefinic epothilone derivatives
Inventor: VITE GREGORY D
IPC: A61K31/5517
Filed: 1999-04-14
Granted: 2003-01-16
Abstract: The present invention relates to 2,3-position modified epothilone derivatives, methods of preparation of the derivatives, and intermediates therefor. The compounds of the invention as 16-membered macrolides having the general structure,which have microtubule-stabilizing effects and cytotoxic activity against rapidly proliferating cells, such as, tumor cells or other hyperproliferative cellular disease.
Patent AU-575601-B2 (AU)
Title: Pulsed high energy density welding
Inventor: SHARP CHARLES MICHAEL
IPC: B23K26/08
Filed: 1984-11-27
Granted: 1988-08-04
Abstract: A method and apparatus for high speed welding are disclosed wherein a continuous weld is formed at high speed along a member with a plurality of overlapping welds formed by pulses of high density energy from a pulsed high energy density welding device such as an electronically pulsed gas laser. The movement of the member being welded is detected in the vicinity of the pulsed laser. The pulsed laser is controlled in response to the detected movement so that the energy for welding from the pulses per unit length of the member being welded is accurately controlled. The control of the laser involves pulsing of the laser in response to the detected movement of the member so that the pitch of the overlapping welds along the member is substantially constant. Also, the power of the laser pulses is controlled and adjusted in a predetermined manner in response to the detected movements. The high speed movement of the member is detected by detecting the leading edge of the moving member at or upstream of the pulsed laser and also continuously decteing the position of the moving member at or as it moves past the pulsed laser. High quality welds can be made in materials at speeds of 22-40 m/min. or more with the method and apparatus.
Patent AU-706317-B2 (AU)
Title: Man-made vitreous fibres
Inventor: JENSEN SOREN LUND
IPC: C03C3/087
Filed: 1995-11-08
Granted: 1999-06-17
Abstract: Man-made vitreous fibres have a solubility at pH 4.5 of at least 20nm per day and a melt viscosity of 10-70 poise at 1,400°C. A composition which will provide these properties is selected for their manufacture and contains at least 105 by weight Al<sub>2</sub>O<sub>3</sub>. Novel fibres contain at least 6% by weight Na<sub>2</sub>O + K<sub>2</sub>O.
Patent AU-778494-B2 (AU)
Title: Methods of treating schizophrenia
Inventor: ALLEN RICHARD C
IPC: A61K35/44
Filed: 2000-03-20
Granted: 2004-12-09
Abstract: The invention provides methods for the treatment of abnormal psychiatric states, particularly the negative symptoms of schizophrenia and extrapyramidal side effects (EPS) of antipsychotic drugs. The inventive methods relate to the administration of therapeutic cells (which produce dopamine or dopamine precursors) adhered to support matrices to subjects suffering from the negative symptoms of schizophrenia and/or EPS. The therapeutic cells may be coadministered with cells which protect the therapeutic cells from immune rejection and/or cells which produce neurotrophic factors which improve the viability of the therapeutic cells.